GMP in IPO Explained: Grey Market Premium & Kostak

What Is GMP in IPO?

Grey Market Premium (GMP) is the unofficial premium at which IPO shares or IPO applications are bought and sold before a company's official listing on the NSE or BSE. If an IPO is priced at ₹200 and the GMP is ₹40, the grey market is unofficially pricing the stock to list around ₹240. GMP is not tracked, verified, or endorsed by SEBI — it is an informal sentiment indicator, not a guaranteed listing price.

What Is the Grey Market?

The grey market is an unofficial, over-the-counter (OTC) marketplace where financial securities — including IPO shares and IPO application forms — are traded before they are officially listed on a stock exchange. It sits between a fully legal, regulated market and an outright illegal “black” market, which is why it is called “grey.”

Trading in the grey market is unofficial and typically trust-based, often conducted in cash and in person through local dealers, with no centralised platform or exchange. None of these transactions are endorsed, cleared, or settled by SEBI, NSE, or BSE. Despite this, the grey market has functioned in India for decades as an early, informal gauge of investor demand for an upcoming IPO.

In the IPO context specifically, the grey market lets investors and traders buy or sell IPO shares — or entire IPO application forms — before the shares are officially credited to demat accounts and listed. It gives issuers and underwriters an early, if unofficial, read on demand for a new offering.

Is Grey Market Trading Legal in India?

This is one of the most common — and most important — questions investors ask, so it deserves a direct answer.

Grey market trading in India is not explicitly illegal, but it is completely unregulated. SEBI, NSE, and BSE do not recognise, endorse, or settle grey market deals. Because these trades are informal, cash-based, and undocumented, participants have no legal recourse if a counterparty defaults on a deal.

This matters because a lot of older content on the internet incorrectly calls the grey market “illegal.” It isn't — but “not illegal” is a very different thing from “safe” or “regulated.” There is no SEBI oversight, no investor protection mechanism, and no formal contract enforcement if the other party walks away from the deal.

REGULATORY UPDATE — SEBI's “When-Listed” Platform

SEBI has been working on a regulated “when-listed” trading mechanism that would let investors trade shares in the T+3 window between IPO allotment and formal listing on the exchanges. The stated goal is to give investors a transparent, regulated alternative during exactly the window the grey market currently fills, reducing reliance on informal and unverifiable GMP figures. Readers should treat this as an evolving regulatory development and check the latest SEBI circulars before relying on it.

How Does IPO Grey Market Premium Work?

GMP is driven purely by demand and supply among grey market participants — there is no formula behind it. Here's a simple illustration:

EXAMPLE

Suppose “Natraj Ltd.” is launching its IPO at an official price of ₹200 per share. If the grey market premium for the IPO is ₹100, traders are informally signalling they expect the stock to list around ₹300 (₹200 + ₹100) — and are willing to pay ₹100 above the issue price today to secure that expected upside.

A rising GMP as the IPO subscription period progresses is generally read as a sign of strong demand; a falling or negative GMP close to listing is generally read as a sign of weakening sentiment. But as Section 8 below shows with real examples, this signal is directional at best — never a guarantee.

What Is IPO Kostak Rate?

The Kostak Rate is the flat amount a buyer pays a seller for an entire IPO application — regardless of whether that application is eventually allotted shares or not. The seller locks in a fixed profit either way.

EXAMPLE

Karthik applies for IPO shares in three separate applications and sells each application in the grey market for ₹4,000. He receives ₹12,000 in total (3 × ₹4,000). Even if only one — or none — of his three applications is eventually allotted shares, Karthik's ₹12,000 profit is unaffected, because the Kostak deal is settled independently of the allotment outcome.

What Is “Subject to Sauda” in the Grey Market?

“Subject to Sauda” (SS) is the opposite of the Kostak deal in one key respect: the seller is paid a premium only if their IPO application actually receives an allotment. If there's no allotment, there's no payout under this arrangement — the trade is void by default, since it was conditional on allotment happening in the first place.

GMP vs. Kostak vs. Subject to Sauda — Quick Comparison

Real Case Studies: When GMP Got It Right (and Wrong)

GMP is often treated as a near-certain predictor of listing gains. Two of the most talked-about IPOs of 2021 show why that's a dangerous assumption:

CASE STUDY — Zomato (2021): GMP Reflected Genuine Demand

Ahead of listing, grey market sentiment around Zomato pointed to strong demand. The stock listed at ₹116 against a ₹76 issue price — a listing-day gain of about 52.6% at open, touching as high as ~82% intraday before settling around 66% higher by the close. In this case, GMP direction broadly matched what happened on listing day.

CASE STUDY — Paytm (2021): GMP Reversed and Misled the Market

Paytm's grey market premium, which had run hot months earlier, had cooled to roughly 1.4% over its ₹2,150 issue price by the time of listing — and briefly slipped negative. Paytm's shares then fell sharply on debut, making it one of the most-cited cautionary tales in Indian IPO history. Investors who assumed a IPO must be “safe” simply because grey market chatter had once been positive were caught off guard when sentiment flipped days before listing.

The lesson: GMP can move quickly, is not based on audited data, and reflects sentiment among a small, unregulated group of traders — not the verdict of the broader market. Treat it as one input, never the deciding factor.

Risks of Grey Market Trading

• No legal recourse: SEBI, NSE, and BSE do not recognise or enforce grey market deals. If the other party defaults, there is no regulator or court-backed process built for this specific transaction type.

• Counterparty risk: Deals rely entirely on trust between two private individuals, typically routed through local dealers.

• Cash-based, undocumented transactions: This creates practical difficulty proving a deal ever took place, and raises compliance concerns for participants.

• Sentiment can reverse fast: As the Paytm case shows, a high GMP weeks before listing offers no guarantee of a positive listing on the actual day.

• No SEBI investor protection: Grievance redressal mechanisms like SCORES do not cover grey market disputes, since these are not SEBI-regulated transactions.

•  Potential for manipulation: Because volumes and participants are unverifiable, GMP figures published by different trackers can vary widely and may not reflect genuine broad-based demand.

How to Use GMP the Right Way

• Treat GMP as one sentiment indicator among many — not a standalone reason to apply for an IPO.

• Cross-check GMP figures across two or three independent trackers; large discrepancies are a red flag on data quality, not just volatility.

• Read the company's RHP (Red Herring Prospectus) for financials, risk factors, and use of proceeds before applying.

• Watch subscription numbers (QIB, HNI, retail) alongside GMP — genuine institutional demand is a stronger signal than grey market chatter alone.

• Never route money or documents through unofficial grey market intermediaries; apply for IPOs only through your SEBI-registered broker or the official ASBA/UPI process.

• Consult a SEBI-registered investment adviser for a personalised view before committing significant capital to any IPO.

Conclusion

Grey Market Premium can be a useful, real-time pulse check on how the market is reading an upcoming IPO — but it is not a substitute for due diligence. As an unofficial, unregulated signal, it has been directionally right for some IPOs, like Zomato, and clearly wrong for others, like Paytm. That inconsistency is exactly why GMP should never be the sole basis for an investment decision.

For most retail investors, the smarter approach is to treat GMP as one small input among several — alongside the company's fundamentals, RHP disclosures, and category-wise subscription numbers — and to apply for IPOs only through the official, SEBI-regulated ASBA/UPI process rather than through unofficial grey market intermediaries.

As SEBI moves ahead with a regulated “when-listed” trading platform, part of the grey market's current role may eventually shift to a safer, formally supervised alternative. Until that happens, informed caution — not GMP alone — remains the best strategy for anyone applying for an IPO.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is only for educational purposes. Always discuss with your SEBI-registered financial advisor for investment-related decisions.

Follow this WhatsApp Channel for the latest updates directly on WhatsApp.